Anti-HIV-1 potency of the CRISPR/Cas9 system insufficient to fully inhibit viral replication
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-HIV-1 potency of the CRISPR/Cas9 system insufficient to fully inhibit viral replication
Authors
Keywords
-
Journal
MICROBIOLOGY AND IMMUNOLOGY
Volume 60, Issue 7, Pages 483-496
Publisher
Wiley
Online
2016-06-09
DOI
10.1111/1348-0421.12395
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CRISPR-Cas9 Can Inhibit HIV-1 Replication but NHEJ Repair Facilitates Virus Escape
- (2016) Gang Wang et al. MOLECULAR THERAPY
- Persistent HIV-1 replication maintains the tissue reservoir during therapy
- (2016) Ramon Lorenzo-Redondo et al. NATURE
- Nuclear architecture dictates HIV-1 integration site selection
- (2015) Bruna Marini et al. NATURE
- Use of the CRISPR/Cas9 system as an intracellular defense against HIV-1 infection in human cells
- (2015) Hsin-Kai Liao et al. Nature Communications
- CRISPR/Cas9 nickase-mediated disruption of hepatitis B virus open reading frame S and X
- (2015) Madina Karimova et al. Scientific Reports
- A High Excision Potential of TALENs for Integrated DNA of HIV-Based Lentiviral Vector
- (2015) Hirotaka Ebina et al. PLoS One
- In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by CRISPR/Cas9
- (2014) Shuai Zhen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- CRISPR/Cas9-mediated genome editing of Epstein-Barr virus in human cells
- (2014) K.-S. Yuen et al. JOURNAL OF GENERAL VIROLOGY
- RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection
- (2014) W. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Characterization of red-capped mangabey tetherin: implication for the co-evolution of primates and their lentiviruses
- (2014) Tomoko Kobayashi et al. Scientific Reports
- High-Efficiency Targeted Editing of Large Viral Genomes by RNA-Guided Nucleases
- (2014) Yanwei Bi et al. PLoS Pathogens
- The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo
- (2014) Su-Ru Lin et al. Molecular Therapy-Nucleic Acids
- DNA targeting specificity of RNA-guided Cas9 nucleases
- (2013) Patrick D Hsu et al. NATURE BIOTECHNOLOGY
- High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
- (2013) Yanfang Fu et al. NATURE BIOTECHNOLOGY
- Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
- (2013) Ophir Shalem et al. SCIENCE
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus
- (2013) Hirotaka Ebina et al. Scientific Reports
- HIV Latency
- (2013) R. F. Siliciano et al. Cold Spring Harbor Perspectives in Medicine
- Vpu Augments the Initial Burst Phase of HIV-1 Propagation and Downregulates BST2 and CD4 in Humanized Mice
- (2012) K. Sato et al. JOURNAL OF VIROLOGY
- Dynamics of memory and naïve CD8+ T lymphocytes in humanized NOD/SCID/IL-2Rγnull mice infected with CCR5-tropic HIV-1
- (2010) Kei Sato et al. VACCINE
- Structure and Function of HIV-1 Reverse Transcriptase: Molecular Mechanisms of Polymerization and Inhibition
- (2008) Stefan G. Sarafianos et al. JOURNAL OF MOLECULAR BIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started